Dr. Shravani R. Reddy, MD

Dr. Reddy practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Reddy's NPI, 1861855686, was assigned on March 30, 2016. Dr. Reddy graduated from American University of the Caribbean in 2016. Dr. Reddy holds California license A162069.

Dr. Reddy's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Reddy's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Reddy is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Reddy's licenses on file in 3 states: California, North Carolina and Virginia.

CMS data shows 616 Medicare services from Dr. Reddy across 11 procedure codes in 2024, for 328 Medicare patients. Medicare paid $57,451 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 328 Medicare patients who saw Dr. Reddy in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 59, with 57% women.

In 2024, Dr. Reddy wrote 439 Medicare Part D claims for 224 patients. 82% of them were for generic drugs. CMS names the drug for 349 of them, across 9 drugs with 11 or more claims each, at $15,420 in total drug cost. In 2023, CMS named 157 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Reddy for performance year 2024, reported through an alternative payment model (APM). Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth. CMS counts 162 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reddy, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Reddy, published from 2020 to 2024. 2021 was the busiest year, with 6. The most frequent topics are Liver Neoplasms. Dr. Reddy has published most often in Cureus. Dr. Reddy's most frequent co-authors are Adil Shamim Mir, MD, Paul Yeaton, MD and Vikas Narayan Chitnavis, MD.

CMS Open Payments shows 27 general payments to Dr. Reddy from 15 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 63% of the total. Steris Corporation paid the most, $1,920.

Dr. Reddy graduated from American University of the Caribbean in 2016.

Dr. Reddy is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.